Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension

J Hypertens. 2024 Jun 1;42(6):1105-1106. doi: 10.1097/HJH.0000000000003691. Epub 2024 May 1.

Authors

David Rubin^{1

2

3}, David F Lo^{1

2

3}, Sriharsha Jammula⁴, Nathan Carroll⁵, Mahesh Vasudevan⁶

Affiliations

¹ Rowan-Virtua School of Osteopathic Medicine, Stratford.
² School of Arts and Sciences, Rutgers University, New Brunswick.
³ Future Forward Research Institute 501(c)3, Toms River.
⁴ Department of Internal Medicine, Virtua Our Lady of Lourdes Hospital, Camden.
⁵ Department of Psychiatry, Jersey Shore University Medical Center, Neptune Township.
⁶ Department of Psychiatry, Rowan-Virtua School of Osteopathic Medicine, Mount Laurel, New Jersey, USA.

PMID: 38690909
DOI: 10.1097/HJH.0000000000003691

No abstract available

Publication types

Editorial

MeSH terms

Antihypertensive Agents* / therapeutic use
Blood Pressure / drug effects
Drug Resistance
Humans
Hypertension* / drug therapy
Treatment Outcome

Substances

Antihypertensive Agents